Citi Raises Hikma Pharmaceuticals Target Following Sector's Robust Growth
Tuesday, 11 June 2024, 05:59
Hikma Pharmaceuticals Shares Target Increase
Hikma Pharmaceuticals' shares target has been upped by Citi, reflecting confidence in the company's performance.
Strong Sector Growth
The pharmaceutical sector is experiencing robust growth, providing an optimistic backdrop for Hikma Pharmaceuticals.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.